secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2023-11-20T23:59:59+00:00
Accession:  0001641489-23-000079
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics executes 1-for-40 reverse stock split to regain Nasdaq $1.00 minimum bid compliance
--------------------------------------------------------------------------------

- Reverse split at 1-for-40 ratio became effective at 4:01 p.m. ET on November 20, 2023.
- Purpose is to regain compliance with Nasdaq's $1.00 minimum closing price for continued listing.
- Fractional shares resulting from the split are rounded up to the nearest whole share.
- Percentage ownership unchanged for each stockholder except for fractional share adjustments.
- Class A common stock continues trading under symbol VTVT with new CUSIP 91835204.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000079/0001641489-23-000079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148923000079/vtvt-20231120.htm
  HTML page:      https://secwatch.observer/filing/0001641489-23-000079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer